Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company, 5881-5882 [2023-01851]

Download as PDF Federal Register / Vol. 88, No. 19 / Monday, January 30, 2023 / Notices Commission employees providing support for the meeting). Nonparticipating individuals may listen to the meeting by calling the phone number listed below in this notice. Any person attending this meeting who requires special accessibility features and/or auxiliary aids, such as sign language interpreters, must inform the Commission in advance of those needs. Subject to 29 CFR 2706.150(a)(3) and 2706.160(d). CONTACT PERSON FOR MORE INFO: Emogene Johnson (202) 434–9935/(202) 708–9300 for TDD Relay/1–800–877– 8339 for toll free. PHONE NUMBER FOR LISTENING TO MEETING: 1 (866) 236–7472, Passcode: 678–100. Authority: 5 U.S.C. 552b. Dated: January 26, 2023. Sarah L. Stewart, Deputy General Counsel. FOR FURTHER INFORMATION CONTACT: David B. Husband, Senior Counsel, (202) 530–6270, or david.b.husband@ frb.gov; Legal Division, Board of Governors of the Federal Reserve System, 20th Street and Constitution Avenue NW, Washington, DC 20551. For users of TDD, please dial 7–1–1 anywhere in the United States to access telecommunication relay services. [FR Doc. 2023–01968 Filed 1–26–23; 4:15 pm] BILLING CODE 6735–01–P FEDERAL RESERVE SYSTEM Privacy Act of 1974; System of Records Pursuant to the provisions of the Privacy Act of 1974, notice is given that the Board of Governors of the Federal Reserve System (Board) proposes to rescind an existing system of records, entitled BGFRS–8, ‘‘FRB— Travel Records.’’ BGFRS–8 included travel authorization forms and supporting documentation, travel expense statements and supporting documentation, applications for government travel cards, records regarding Board reimbursement of travel expenses, and records regarding reservations for transportation and lodging sent to the Board’s Travel Office. DATES: January 30, 2023. ADDRESSES: You may submit comments, identified by BGFRS–8 ‘‘FRB—Travel Records,’’ by any of the following methods: • Agency Website: https:// www.federalreserve.gov. Follow the instructions for submitting comments at https://www.federalreserve.gov/apps/ foia/proposedregs.aspx. • Email: regs.comments@ federalreserve.gov. Include SORN name and number in the subject line of the message. lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: 18:01 Jan 27, 2023 Jkt 259001 The Board is discontinuing BGFRS–8, ‘‘FRB— Travel Records’’ because the Board shifted its travel processes to the General Services Administration (GSA) E2 travel system in 2009. Therefore, the Board’s current travel records are covered by the GSA government-wide system of records GSA/GOVT–4 Contracted Travel Services Program (ETravel), which is published in the Federal Register at 74 FR 26700 (June 3, 2009). The retention periods for the Board’s historic travel records expired in 2015 (six years after final payment or cancellation) or 2019 (for records related to overcharges or deductions). Thus, consistent with the applicable records retention schedule, the Board no longer retains or possesses historic travel records. Accordingly, the Board no longer requires BGFRS–8 ‘‘FRB-Travel Records,’’ and is providing notice of the discontinuation of this system. SUPPLEMENTARY INFORMATION: Board of Governors of the Federal Reserve System. ACTION: Rescindment of a system of records notice. AGENCY: VerDate Sep<11>2014 • Fax: (202) 452–3819 or (202) 452– 3102. • Mail: Ann E. Misback, Secretary, Board of Governors of the Federal Reserve System, 20th Street and Constitution Avenue NW, Washington, DC 20551. All public comments will be made available on the Board’s website at https://www.federalreserve.gov/apps/ foia/proposedregs.aspx as submitted, unless modified for technical reasons or to remove sensitive personally identifiable information. Public comments may also be viewed electronically and printed in Room 146, 1709 New York Avenue NW, Washington, DC 20006, between 9 a.m. and 5 p.m. on weekdays. SYSTEM NAME AND NUMBER: BGFRS–8 ‘‘FRB—Travel Records.’’ HISTORY: This SORN was previously published in the Federal Register at 73 FR 24984 at 24993 (May 6, 2008). The SORN was also amended to incorporate two new routine uses required by OMB at 83 FR 43872 (August 28, 2018). PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 5881 Board of Governors of the Federal Reserve System. Ann Misback, Secretary of the Board. [FR Doc. 2023–01759 Filed 1–27–23; 8:45 am] BILLING CODE P FEDERAL RESERVE SYSTEM Change in Bank Control Notices; Acquisitions of Shares of a Bank or Bank Holding Company The notificants listed below have applied under the Change in Bank Control Act (Act) (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire shares of a bank or bank holding company. The factors that are considered in acting on the applications are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)). The public portions of the applications listed below, as well as other related filings required by the Board, if any, are available for immediate inspection at the Federal Reserve Bank(s) indicated below and at the offices of the Board of Governors. This information may also be obtained on an expedited basis, upon request, by contacting the appropriate Federal Reserve Bank and from the Board’s Freedom of Information Office at https://www.federalreserve.gov/foia/ request.htm. Interested persons may express their views in writing on the standards enumerated in paragraph 7 of the Act. Comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors, Ann E. Misback, Secretary of the Board, 20th Street and Constitution Avenue NW, Washington, DC 20551–0001 not later than February 14, 2023. A. Federal Reserve Bank of San Francisco (Joseph Cuenco, Assistant Vice President, Formations, Transactions and Enforcement) 101 Market Street, San Francisco, California 94105. 1. FinTech HQ Inc., Vancouver, Washington; to acquire additional voting shares of Lewis & Clark Bancorp, and thereby indirectly acquire voting shares of Lewis & Clark Bank, both of Oregon City, Oregon. 2. FinTech HQ Inc., Vancouver, Washington; to acquire additional voting shares of Pacific West Bancorp, and thereby indirectly acquire voting shares of Pacific West Bank, both of West Linn, Oregon. E:\FR\FM\30JAN1.SGM 30JAN1 5882 Federal Register / Vol. 88, No. 19 / Monday, January 30, 2023 / Notices Board of Governors of the Federal Reserve System. Margaret McCloskey Shanks, Deputy Secretary of the Board. [FR Doc. 2023–01851 Filed 1–27–23; 8:45 am] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. Centers for Disease Control and Prevention [FR Doc. 2023–01800 Filed 1–27–23; 8:45 am] lotter on DSK11XQN23PROD with NOTICES1 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)–RFA–IP–23– 002, Understanding Adult Immunization Quality Improvement Approaches Among Adult HCP and Health Departments; and RFA–IP–23– 003, Programmatic Interventions To Increase Uptake of Influenza and COVID–19 Vaccination Among Students Attending Institutions of Higher Education; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA– IP–23–002, Understanding Adult Immunization Quality Improvement Approaches Among Adult HCP and Health Departments; and RFA–IP–23– 003, Programmatic Interventions To Increase Uptake of Influenza and COVID–19 Vaccination Among Students Attending Institutions of Higher Education; March 29–30, 2023, 10 a.m.– 5 p.m. EDT, Teleconference, Centers for Disease Control and Prevention, Room 1080, 8 Corporate Boulevard, Atlanta, Georgia, 30329, in the original FRN. The meeting was published in the Federal Register on December 23, 2022, Volume 87, Number 246, pages/s/78968–78969. The meeting is being amended to remove the second day of the meeting and should read as follows: Date: March 29, 2023. Time: 10 a.m.–5 p.m. (EDT). Place: Teleconference, Centers for Disease Control and Prevention, Room 1077, 8 Corporate Blvd., Atlanta, GA 30329. The meeting is closed to the public. FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop US8–1, Atlanta, Georgia 30329–4027; Telephone: (404) 718–8833; Email: GAnderson@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease VerDate Sep<11>2014 17:30 Jan 27, 2023 Jkt 259001 Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Health Statistics (NCHS), ICD–10 Coordination and Maintenance (C&M) Committee Meeting Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: The CDC, National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, announces the following meeting of the ICD–10 Coordination and Maintenance (C&M) Committee. This meeting is open to the public, limited only by the number of audio lines available. Online registration is required. DATES: The meeting will be held on March 7, 2023, from 9 a.m. to 5 p.m., EST, and March 8, 2023, from 9 a.m. to 5 p.m., EST. ADDRESSES: This is a virtual meeting. Register in advance at https:// cms.zoomgov.com/webinar/register/ WN__piUmNYaRjmkcYczb3ePIQ. After registering, you will receive a confirmation email containing information about joining the meeting. Further information will be provided on each of the respective web pages when it becomes available. For the Centers for Disease Control and Prevention, National Center for Health Statistics: https://www.cdc.gov/nchs/icd/icd10cm_ maintenance.htm. For the Centers for Medicare & Medicaid Services, Department of Health and Human Services: https://www.cms.gov/ Medicare/Coding/ICD10/C-and-MMeeting-Materials. FOR FURTHER INFORMATION CONTACT: Traci Ramirez, Medical Systems Specialist, National Center for Health Statistics, CDC, 3311 Toledo Road, Hyattsville, Maryland 20782–2064; SUMMARY: PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 Telephone: (301) 458–4454; Email: TRamirez@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The ICD–10 Coordination and Maintenance (C&M) Committee is a public forum for the presentation of proposed modifications to the International Classification of Diseases, Tenth Revision, Clinical Modification (CM) and ICD–10 Procedure Coding System (PCS). Matters To Be Considered: The tentative agenda will include discussions on the ICD–10–CM and ICD–10–PCS topics listed below. Agenda items are subject to change as priorities dictate. Please refer to the posted agenda for updates one month prior to the meeting. ICD–10–PCS Topics 1. Administration of Elranatamab * 2. Administration of Epcoritamab * 3. Administration of Glofitamab * 4. Administration of Pafolacianine * 5. Administration of Posoleucel ** 6. Administration of Quizartinib * 7. Administration of Rezafungin * 8. Administration of SER–109 * 9. Administration of SulbactamDurlobactam * 10. Implantation of Bioprosthetic Femoral Venous Valves 11. Rapid Antimicrobial Susceptibility Testing of Blood Cultures * 12. Dual-Chamber Leadless Cardiac Pacemaker * 13. Percutaneous Femoral-Popliteal Artery Bypass * 14. Insertion of Lengthening Device for Esophageal Atresia 15. Implantation of Extraluminal Saphenous Vein Graft Support Device During Coronary Artery Bypass Graft (CABG) * 16. Short-term External Heart Assist with Graft 17. Ultrasound Ablation of Renal Sympathetic Nerves * 18. Computer-aided Detection of Heart Failure in Echocardiography * 19. Percutaneous Mechanical Circulatory Support 20. Monitoring of Intracranial Electrical Activity for Status Epilepticus * 21. Monitoring of Intracranial Electrical Activity for Delirium * 22. Rapid Antimicrobial Susceptibility Testing System for Blood and Body Fluid Cultures * 23. Percutaneous Hepatic Perfusion with Administration of Melphalan Hydrochloride ** 24. Insertion of Muscle Compartment Pressure Monitor * 25. Insertion of Tibial Extension Implant During Total Knee Arthroplasty * 26. Talar Replacement of Ankle * 27. Ankle Fusion with Truss Implant * E:\FR\FM\30JAN1.SGM 30JAN1

Agencies

[Federal Register Volume 88, Number 19 (Monday, January 30, 2023)]
[Notices]
[Pages 5881-5882]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-01851]


-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM


Change in Bank Control Notices; Acquisitions of Shares of a Bank 
or Bank Holding Company

    The notificants listed below have applied under the Change in Bank 
Control Act (Act) (12 U.S.C. 1817(j)) and Sec.  225.41 of the Board's 
Regulation Y (12 CFR 225.41) to acquire shares of a bank or bank 
holding company. The factors that are considered in acting on the 
applications are set forth in paragraph 7 of the Act (12 U.S.C. 
1817(j)(7)).
    The public portions of the applications listed below, as well as 
other related filings required by the Board, if any, are available for 
immediate inspection at the Federal Reserve Bank(s) indicated below and 
at the offices of the Board of Governors. This information may also be 
obtained on an expedited basis, upon request, by contacting the 
appropriate Federal Reserve Bank and from the Board's Freedom of 
Information Office at https://www.federalreserve.gov/foia/request.htm. 
Interested persons may express their views in writing on the standards 
enumerated in paragraph 7 of the Act.
    Comments regarding each of these applications must be received at 
the Reserve Bank indicated or the offices of the Board of Governors, 
Ann E. Misback, Secretary of the Board, 20th Street and Constitution 
Avenue NW, Washington, DC 20551-0001 not later than February 14, 2023.
    A. Federal Reserve Bank of San Francisco (Joseph Cuenco, Assistant 
Vice President, Formations, Transactions and Enforcement) 101 Market 
Street, San Francisco, California 94105.
    1. FinTech HQ Inc., Vancouver, Washington; to acquire additional 
voting shares of Lewis & Clark Bancorp, and thereby indirectly acquire 
voting shares of Lewis & Clark Bank, both of Oregon City, Oregon.
    2. FinTech HQ Inc., Vancouver, Washington; to acquire additional 
voting shares of Pacific West Bancorp, and thereby indirectly acquire 
voting shares of Pacific West Bank, both of West Linn, Oregon.


[[Page 5882]]


    Board of Governors of the Federal Reserve System.
Margaret McCloskey Shanks,
Deputy Secretary of the Board.
[FR Doc. 2023-01851 Filed 1-27-23; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.